Priscilla Wander
Utrecht, UT 3584CS, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia.
Journal: International journal of molecular sciences
Published: July 02, 2023
High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling.
Journal: Biomedicines
Published: January 28, 2022
High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia.
Journal: Translational oncology
Published: January 22, 2021
Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia.
Journal: Leukemia
Published: March 01, 2020
The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia.
Journal: Haematologica
Published: September 16, 2019
FLT3N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis.
Journal: Leukemia
Published: December 06, 2018
Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo.
Journal: Haematologica
Published: February 09, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026